-
Product Insights
NewNet Present Value Model: Intra-Cellular Therapies Inc’s Lenrispodun Phosphate
Empower your strategies with our Net Present Value Model: Intra-Cellular Therapies Inc's Lenrispodun Phosphate report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewNet Present Value Model: Sun Pharmaceutical Industries Ltd’s Deuruxolitinib Phosphate
Empower your strategies with our Net Present Value Model: Sun Pharmaceutical Industries Ltd's Deuruxolitinib Phosphate report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Infigratinib Phosphate in Achondroplasia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Infigratinib Phosphate in Achondroplasia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Infigratinib Phosphate in Achondroplasia Drug Details: Infigratinib phosphate (Truseltiq) is an...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Ruxolitinib Phosphate in Vitiligo
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ruxolitinib Phosphate in Vitiligo report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ruxolitinib Phosphate in Vitiligo Drug Details: Ruxolitinib (INCB18424, Jakafi, Jakavi) is an...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Ruxolitinib Phosphate in Seborrhea
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ruxolitinib Phosphate in Seborrhea report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ruxolitinib Phosphate in Seborrhea Drug Details: Ruxolitinib (INCB18424, Jakafi, Jakavi) is an...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Povorcitinib Phosphate in Prurigo
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Povorcitinib Phosphate in Prurigo report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Povorcitinib Phosphate in Prurigo Drug Details: Povorcitinib (INCB-54707) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Povorcitinib Phosphate in Asthma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Povorcitinib Phosphate in Asthma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Povorcitinib Phosphate in Asthma Drug Details: Povorcitinib (INCB-54707) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Povorcitinib Phosphate in Vitiligo
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Povorcitinib Phosphate in Vitiligo report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Povorcitinib Phosphate in Vitiligo Drug Details: Povorcitinib (INCB-54707) is under development...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Ruxolitinib Phosphate in Hand Dermatitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ruxolitinib Phosphate in Hand Dermatitis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ruxolitinib Phosphate in Hand Dermatitis Drug Details: Ruxolitinib (INCB18424, Jakafi, Jakavi)...